← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2000First marketed drug
Dec 13, 2016First NDA
Dec 13, 2016Last known activity
Jul 31, 2018
Timeline
1980s
- Jun 1, 1989
Vericel Corporation— Founded
2010s
- Dec 13, 2016
autologous culture chondrocytes— NDA Organization
Drugs by trial phase (5 distinct, 12 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (12)
- NCT03588975Lead sponsorPhase 3Jul 31, 2018
- NCT01670981Lead sponsorPhase 2Oct 1, 2012
- NCT01483898Lead sponsorPhase 3Feb 1, 2012
- NCT01020968Lead sponsorPhase 2Dec 1, 2009
- NCT00765518Lead sponsorPhase 2Sep 1, 2008
- NCT00719576Lead sponsorPhase 3Jul 1, 2008
- NCT00755911CollaboratorPhase 1/Phase 2Jun 1, 2008
- NCT00505219Lead sponsorPhase 2Sep 1, 2007
- NCT00468000Lead sponsorPhase 2Apr 1, 2007
- NCT00797550Lead sponsorPhase 1/Phase 2Apr 1, 2006
- NCT00424567Lead sponsorPhase 1/Phase 2Oct 1, 2003
- NCT00158613Lead sponsorPhase 4Mar 1, 2000
Details
- Founded
- Ann Arbor, MI, US Jun 1, 1989
- First NDA
- Dec 13, 2016
- Last known activity
- Jul 31, 2018